• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. JRNY II CR FEM OX NP LT SZ 4; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. JRNY II CR FEM OX NP LT SZ 4; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Model Number 74021164
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 08/24/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Event or Problem Description
It was reported that, after a tka surgery was performed on (b)(6) 2019, the patient experienced vein thrombosis on the left lower extremity.This adverse event was treated with medication & physical therapy.Patient's current health status is recovered.
 
Additional Manufacturer Narrative
H3, h6: the devices were not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that, per complaint details, the study patient experienced adverse event vein thrombosis on the left lower extremity post left jii xr total knee arthroplasty which was resolved with medication and physical therapy.The jii xr pmcf operative data for (b)(6) 2019 surgery date documents 94 minutes total tourniquet time.As of the date of this medical investigation, further details such as symptom onset remain unknown; however, the concomitant medication documentation shows heparin was started approximately two weeks post total knee arthroplasty on (b)(6) 2019 and ended (b)(6) 2019 for the associated.The occurrence of post-operative deep vein thrombosis is a known potential risk/adverse hematological event and is not indicative of any component malperformance.Based on the information provided, no further clinical factors could be definitively concluded to have contributed to the reported event.Patient impact beyond the reported post-primary total knee arthroplasty lower leg thrombosis and subsequent medication along with physical therapy would not be anticipated as the event was reportedly resolved.No further medical assessment can be rendered at this time.A review of the production order did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history for the part number over the past 12 months and for the batch number based on historical data of the devices did not reveal similar events for the listed devices.A review of the instructions for use documents for knee systems revealed that thromboembolic diseases including venous thrombosis has been identified in possible adverse effects.A review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to these products and event.At this time, we have no reason to suspect that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include post-operative healing issue and/or patient condition.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JRNY II CR FEM OX NP LT SZ 4
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key16569273
Report Number1020279-2023-00577
Device Sequence Number12132701
Product Code JWH
UDI-Device Identifier00885556422793
UDI-Public00885556422793
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K121443
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source Other,Foreign,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 04/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number74021164
Device Catalogue Number74021164
Device Lot Number18EM00183
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/20/2023
Supplement Date Received by Manufacturer04/05/2023
Initial Report FDA Received Date03/17/2023
Supplement Report FDA Received Date04/11/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured05/01/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device A
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
71420566 / 19BM18168.; 74022203 / 18ESL0008.; 74023740 / 17LM18849.; 74023840 / 18AM00951.
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-